What is TherapeuticsMD?
TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing novel products specifically for women. The company's therapeutic focus spans family planning, reproductive health, and menopause management, aiming to address the unique health changes and challenges women encounter throughout their lives. TherapeuticsMD is committed to improving women's health outcomes and raising awareness for their specific healthcare needs. Headquartered in Boca Raton, Florida, the company has historically pursued a strategy involving various forms of capital infusion, including debt financing and stock issuances, to fuel its development and commercialization efforts.
How much funding has TherapeuticsMD raised?
TherapeuticsMD has raised a total of $918.6M across 12 funding rounds:
Stock Offering
$42.8M
Stock Offering
$59.1M
Stock Offering
$32.2M
Stock Offering
$144M
Stock Offering
$68.5M
Stock Offering
$90M
Debt
$300M
Stock Offering
$77M
Private Equity
$15M
Stock Issuance/Offering (2014): $42.8M featuring Undisclosed
Stock Issuance/Offering (2015): $59.1M backed by Undisclosed
Stock Issuance/Offering (2015): $32.2M with participation from Undisclosed
Stock Issuance/Offering (2016): $144M led by Undisclosed
Stock Issuance/Offering (2017): $68.5M supported by Undisclosed
Stock Issuance/Offering (2018): $90M featuring Undisclosed
Debt (2019): $300M backed by Sixth Street Partners
Stock Issuance/Offering (2019): $77M with participation from Undisclosed
Private Equity (2022): $15M led by Rubric Capital Management
Key Investors in TherapeuticsMD
Sixth Street Partners
Sixth Street Partners is a global investment firm known for providing flexible, long-term capital and innovative solutions across diverse sectors, including healthcare. Their involvement suggests a strategic partnership aimed at supporting TherapeuticsMD's growth and development initiatives.
Rubric Capital Management
Rubric Capital Management LP is an investment management firm based in New York, specializing in delivering superior returns through disciplined portfolio management. Their participation in this private equity round indicates confidence in TherapeuticsMD's market position and future prospects.
Undisclosed Investors
What's next for TherapeuticsMD?
With a history of substantial enterprise-level funding and strategic investments, TherapeuticsMD is positioned for continued growth and product development in the women's health sector. The company's focus on addressing unmet needs in family planning, reproductive health, and menopause management suggests a strategic direction towards expanding its product portfolio and market reach. Future endeavors will likely involve leveraging its established therapeutic focus and capital base to further innovate and potentially explore new market opportunities within the broader healthcare landscape, aiming to solidify its leadership in women's specialized healthcare solutions.
See full TherapeuticsMD company page
